Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma
Access Status
Authors
Date
2010Type
Metadata
Show full item recordCitation
Source Title
ISSN
School
Collection
Abstract
Background: Malignant mesothelioma is an aggressive, almost uniformly fatal tumor, primarily caused by exposure to asbestos. Since the recent discovery that serum mesothelin is a sensitive and highly specific biomarker for mesothelioma, one of the key issues raised is whether mesothelin levels represent a useful screening test for asbestos-exposed at-risk individuals. In this study, soluble mesothelin was determined in sequential serum samples collected from asbestos-exposed individuals before the development of mesothelioma. Methods: Archival serum samples from 106 individuals who developed mesothelioma, 99 asbestosexposed individuals from the Wittenoom Cancer Surveillance Program, and 109 non-asbestos-exposed individuals from the Busselton Health Survey were identified. Serum mesothelin concentrations were determined using the MESOMARK assay. Results: Longitudinal mesothelin levels determined in healthy asbestos-exposed individuals over a period of 4 years were stable (Pearson's r = 0.96; P < 0.0001). There was no correlation between mesothelin concentration and cumulative asbestos exposure. Mesothelin concentrations were greater than the threshold value of 2.5 nmol/L in the penultimate serum sample before the diagnosis of mesothelioma in 17 of 106 people. Using an increase above the 95% confidence interval of the mean of a given individual's longitudinal mesothelin results, 33 of 82 individuals had increasing mesothelin levels before diagnosis. Conclusion: In a population with a high pretest probability of developing mesothelioma, the serum biomarker mesothelin is elevated in absolute terms in 15% and in relative terms in 40% of the group. Impact: Future studies examining a combination of biomarkers could improve sensitivity of screening. ©2010 AACR.
Related items
Showing items related by title, author, creator and subject.
-
Cadby, G.; Mukherjee, S.; Musk, A.; Reid, A.; Garlepp, Michael; Dick I.; Robinson, C.; Hui, J.; Fiorito, G.; Guarrera, S.; Beilby, J.; Melton, P.; Moses, E.; Ugolini, D.; Mirabelli, D.; Bonassi, S.; Magnani, C.; Dianzani, I.; Matullo, G.; Robinson, B.; Creaney, J.; Palmer, L. (2013)Malignant mesothelioma (MM) is a uniformly fatal tumour of mesothelial cells. MM is caused by exposure to asbestos however most individuals with documented asbestos exposure do not develop MM. Although MM appears to ...
-
Robinson, C.; Alfonso, Helman; Woo, S.; Walsh, A.; Olsen, N.; Musk, A.; Robinson, B.; Nowak, A.; Lake, R. (2014)Mesothelioma is principally caused by asbestos and may be preventable because there is a long latent period between exposure and disease development. The most at-risk are a relatively well-defined population who were ...
-
Murray, C.; Wong, P.; Teh, J.; de Klerk, N.; Rosenow, T.; Alfonso, Helman; Reid, Alison; Franklin, P.; Musk, A.; Brims, F. (2016)Background and objective: Computed tomography (CT)-based studies of asbestos-exposed individuals report a high prevalence of lung cancer, but the utility of low dose CT (LDCT) to screen asbestos-exposed populations is not ...